SMT201400037B - Nuovi agenti antibatterici per il trattamento di infezioni grampositive - Google Patents

Nuovi agenti antibatterici per il trattamento di infezioni grampositive

Info

Publication number
SMT201400037B
SMT201400037B SM201400037T SM201400037T SMT201400037B SM T201400037 B SMT201400037 B SM T201400037B SM 201400037 T SM201400037 T SM 201400037T SM 201400037 T SM201400037 T SM 201400037T SM T201400037 B SMT201400037 B SM T201400037B
Authority
SM
San Marino
Prior art keywords
gram
treatment
antibacterial agents
new antibacterial
positive infections
Prior art date
Application number
SM201400037T
Other languages
English (en)
Italian (it)
Inventor
Andre Lee Pearson
Chester A Metcalf Iii
Jing Li
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of SMT201400037B publication Critical patent/SMT201400037B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201400037T 2008-12-22 2014-03-28 Nuovi agenti antibatterici per il trattamento di infezioni grampositive SMT201400037B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13987508P 2008-12-22 2008-12-22
PCT/US2009/068747 WO2010075215A1 (en) 2008-12-22 2009-12-18 Novel antibacterial agents for the treatment of gram positive infections

Publications (1)

Publication Number Publication Date
SMT201400037B true SMT201400037B (it) 2014-05-07

Family

ID=41718893

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400037T SMT201400037B (it) 2008-12-22 2014-03-28 Nuovi agenti antibatterici per il trattamento di infezioni grampositive

Country Status (27)

Country Link
US (3) US8507647B2 (sl)
EP (2) EP2674437A1 (sl)
JP (1) JP5670914B2 (sl)
KR (1) KR101717795B1 (sl)
CN (1) CN102325787B (sl)
AR (1) AR074833A1 (sl)
AU (1) AU2009330245C1 (sl)
BR (1) BRPI0923567A2 (sl)
CA (1) CA2747965C (sl)
CY (1) CY1114883T1 (sl)
DK (1) DK2379580T3 (sl)
ES (1) ES2442167T3 (sl)
HK (1) HK1161886A1 (sl)
HR (1) HRP20131170T1 (sl)
IL (1) IL213638A0 (sl)
MX (1) MX2011006803A (sl)
NZ (1) NZ594019A (sl)
PL (1) PL2379580T3 (sl)
PT (1) PT2379580E (sl)
RS (1) RS53152B (sl)
RU (1) RU2512396C2 (sl)
SG (1) SG172299A1 (sl)
SI (1) SI2379580T1 (sl)
SM (1) SMT201400037B (sl)
TW (1) TWI444198B (sl)
WO (1) WO2010075215A1 (sl)
ZA (1) ZA201104693B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012162567A1 (en) * 2011-05-26 2012-11-29 Cubist Pharmaceuticals, Inc. Cb-183,315 compositions and related methods
US10377699B2 (en) * 2013-11-06 2019-08-13 The University Of Hong Kong Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
EP3445767B1 (en) * 2016-04-22 2020-02-19 Astrazeneca AB Macrocyclic mcl1 inhibitors for treating cancer
US10098890B2 (en) 2016-10-29 2018-10-16 Cipla Limited Stable carfilzomib formulations
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32333E (en) * 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
US4812470A (en) 1982-02-27 1989-03-14 Beecham Group P.L.C. Antibacterial monic acid derivatives
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
PT81265B (pt) 1984-10-09 1988-02-17 Lilly Co Eli Processo aperfeicoado para a producao de antibioticos derivados do peptideo ciclico a-21978c
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
CA2043762C (en) * 1990-06-07 2001-05-29 Adam J. Kreuzman Lipopeptide deacylase
EP0712405A1 (en) 1993-08-13 1996-05-22 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE439433T1 (de) 1996-03-08 2009-08-15 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
EP1115417B1 (en) 1998-09-25 2006-04-05 Cubist Pharmaceuticals, Inc. Use of daptomycin
WO2001033274A2 (en) 1999-11-03 2001-05-10 The Whitaker Corporation Optoelectric module for multi-fiber arrays
EP2295444A3 (en) * 1999-12-15 2011-03-23 Cubist Pharmaceutical Inc. Lipopeptides as antibacterial agents
KR20020063228A (ko) 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
KR20020063230A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서의 신규한 리포펩티드
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
AU2002353775A1 (en) 2001-08-06 2003-03-10 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1814588A2 (en) 2004-11-12 2007-08-08 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides

Also Published As

Publication number Publication date
CY1114883T1 (el) 2016-12-14
AU2009330245A1 (en) 2011-08-04
HK1161886A1 (en) 2012-08-10
KR20110114592A (ko) 2011-10-19
JP2012513467A (ja) 2012-06-14
CN102325787B (zh) 2014-05-28
IL213638A0 (en) 2011-07-31
DK2379580T3 (da) 2014-01-20
SG172299A1 (en) 2011-07-28
KR101717795B1 (ko) 2017-03-17
EP2674437A1 (en) 2013-12-18
ZA201104693B (en) 2013-01-30
EP2379580A1 (en) 2011-10-26
CA2747965A1 (en) 2010-07-01
TW201028161A (en) 2010-08-01
CN102325787A (zh) 2012-01-18
US20100184649A1 (en) 2010-07-22
TWI444198B (zh) 2014-07-11
JP5670914B2 (ja) 2015-02-18
US8507647B2 (en) 2013-08-13
NZ594019A (en) 2013-08-30
ES2442167T3 (es) 2014-02-10
RS53152B (en) 2014-06-30
PT2379580E (pt) 2014-01-20
US20140073558A1 (en) 2014-03-13
US20150337013A1 (en) 2015-11-26
PL2379580T3 (pl) 2014-05-30
AU2009330245B2 (en) 2013-05-02
BRPI0923567A2 (pt) 2016-09-27
AU2009330245C1 (en) 2013-09-26
RU2011130278A (ru) 2013-01-27
RU2512396C2 (ru) 2014-04-10
CA2747965C (en) 2017-06-27
HRP20131170T1 (hr) 2014-01-03
EP2379580B1 (en) 2013-10-23
SI2379580T1 (sl) 2014-02-28
WO2010075215A1 (en) 2010-07-01
MX2011006803A (es) 2011-09-06
AR074833A1 (es) 2011-02-16

Similar Documents

Publication Publication Date Title
SMT201400037B (it) Nuovi agenti antibatterici per il trattamento di infezioni grampositive
HK1226411A1 (zh) 大環內酯類抗菌劑的製備方法
SMT201500117B (it) Composti antibatterici
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
ES2898695T8 (es) Derivados de benzoxaborol para el tratamiento de infecciones bacterianas
ATE507225T1 (de) Antibakterielle polycyclische harnstoffverbindungen
BR112012002628A2 (pt) "composição para tratamento de infecções por hbv"
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
ZA200906349B (en) Combination medicaments for treating bacterial infections
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
BRPI0813670A2 (pt) Compostos para tratamento
SMT201500086B (it) Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium
BR112012004676A2 (pt) método de tratar infecções orotomixovirais.
BRPI1014767A2 (pt) métodos de tratamento de infecções bacterianas usando oritavancina
BR112012004643A2 (pt) compostos antibióticos
BR112012004587A2 (pt) composto antibacteriano de hidroxifenila
BR112012002267A2 (pt) compostos para o tratamento de inflamação.
EP2271328A4 (en) ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS
IT1392206B1 (it) Apparato per la produzione di spazzole o scope
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
ZA201100468B (en) The treatment of helminthic infections
DK2321306T3 (da) 3-Cyanopyrrolidinyl-phenyl-oxazolidinoner som antibakterielle midler
BRPI0922216A2 (pt) tratamento para glomerulonefrite
TH0901005768A (th) สารต้านเชื้อแบคทีเรียชนิดใหม่สำหรับรักษาการติดเชื้อแบคทีเรียแกรมบวก
DK2010202T3 (da) Antibakterielle forbindelser